Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Fox

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Cellular & Molecular Immunology|September 6, 2022
Extracellular sulfatase-2 is overexpressed in rheumatoid arthritis and mediates the TNF-α-induced inflammatory activation of synovial fibroblastsRuby J Siegel, Anil K Singh, Paul M Panipinto, et al.
Science Advances|October 29, 2020
Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritisLiam J O'Neil, Ana Barrera-Vargas, Donavon Sandoval-Heglund, et al.
Journal of the American Society of Nephrology : JASN|July 25, 2008
CD19+CD5+ B cells in primary IgA nephropathyHe Yuling, Xiao Ruijing, Ji Xiang, et al.
Cellular & Molecular Immunology|June 15, 2019
Macrophages are the primary effector cells in IL-7-induced arthritisSeung-Jae Kim, Huan J Chang, Michael V Volin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2019
Angiogenic and Arthritogenic Properties of the Soluble Form of CD13Yuxuan Du, Chenyang Lu, Rachel L Morgan, et al.
Journal of Medicinal Chemistry|April 6, 2019
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for SclerodermaDylan J Kahl, Kim M Hutchings, Erika Mathes Lisabeth, et al.
Cellular & Molecular Immunology|January 29, 2026
TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapyFarheen S Shaikh, Meena A Shanta, Anil K Singh, et al.
Science Immunology|June 27, 2017
Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritisCarmelo Carmona-Rivera, Philip M Carlucci, Erica Moore, et al.
Cell Chemical Biology|August 19, 2017
Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune DiseaseJuliane Totzke, Deepak Gurbani, Rene Raphemot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 13, 2025
Differences in dynamics of specific anti-nuclear antibodies and their susceptibility to B cell targeting treatment in Systemic Lupus ErythematosusHugo J van Dooren, Mieke van Schaik, Annemarie L Dorjée, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Cellular & Molecular Immunology|September 6, 2022
Extracellular sulfatase-2 is overexpressed in rheumatoid arthritis and mediates the TNF-α-induced inflammatory activation of synovial fibroblastsRuby J Siegel, Anil K Singh, Paul M Panipinto, et al.
Science Advances|October 29, 2020
Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritisLiam J O'Neil, Ana Barrera-Vargas, Donavon Sandoval-Heglund, et al.
Journal of the American Society of Nephrology : JASN|July 25, 2008
CD19+CD5+ B cells in primary IgA nephropathyHe Yuling, Xiao Ruijing, Ji Xiang, et al.
Cellular & Molecular Immunology|June 15, 2019
Macrophages are the primary effector cells in IL-7-induced arthritisSeung-Jae Kim, Huan J Chang, Michael V Volin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 14, 2019
Angiogenic and Arthritogenic Properties of the Soluble Form of CD13Yuxuan Du, Chenyang Lu, Rachel L Morgan, et al.
Journal of Medicinal Chemistry|April 6, 2019
5-Aryl-1,3,4-oxadiazol-2-ylthioalkanoic Acids: A Highly Potent New Class of Inhibitors of Rho/Myocardin-Related Transcription Factor (MRTF)/Serum Response Factor (SRF)-Mediated Gene Transcription as Potential Antifibrotic Agents for SclerodermaDylan J Kahl, Kim M Hutchings, Erika Mathes Lisabeth, et al.
Cellular & Molecular Immunology|January 29, 2026
TWEAK receptor (Fn14) exacerbates TNF-α-induced inflammation in rheumatoid arthritis synovial fibroblasts and influences response to anti-TNF-α therapyFarheen S Shaikh, Meena A Shanta, Anil K Singh, et al.
Science Immunology|June 27, 2017
Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritisCarmelo Carmona-Rivera, Philip M Carlucci, Erica Moore, et al.
Cell Chemical Biology|August 19, 2017
Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune DiseaseJuliane Totzke, Deepak Gurbani, Rene Raphemot, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 13, 2025
Differences in dynamics of specific anti-nuclear antibodies and their susceptibility to B cell targeting treatment in Systemic Lupus ErythematosusHugo J van Dooren, Mieke van Schaik, Annemarie L Dorjée, et al.
Pageof 16